RxSight, Inc. planned insider sales
In the last twelve months insiders at RxSight, Inc. filed 5 Form 144 notices of planned sales, 28,837 shares worth $193,700 at the time of filing, from 5 sellers. The latest, filed 2 September 2026: Goldshleger Ilya (officer), 2,041 shares worth $14,205, planned for around 2 September 2026 through E-Trade Financial Corporation.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 2 September 2026 | Goldshleger Ilya | Officer | 2,041 | $14,205 | 2 September 2026 | 2,041 shares from 2 September 2026 | E-Trade Financial Corporation | Restricted Stock Units | Form 144 |
| 2 September 2026 | Weinberg Eric | Officer | 2,041 | $14,205 | 2 September 2026 | 2,041 shares from 2 September 2026 | E-Trade Financial Corporation | Restricted Stock Units | Form 144 |
| 2 September 2026 | Kurtz Ronald M MD | Officer | 5,100 | $35,496 | 2 September 2026 | 5,100 shares from 2 September 2026 | E-Trade Financial Corporation | Restricted Stock Units | Form 144 |
| 2 September 2026 | Wilterding Mark | Officer | 7,765 | $54,044 | 2 September 2026 | 7,765 shares from 2 September 2026 | E-Trade Financial Corporation | Restricted Stock Units | Form 144 |
| 18 August 2026 | Raymond W Cohen | Former Director | 11,890 | $75,749 | 18 August 2026 | None on Form 4 yet | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.